INCY
INCYTE CORP
Key Financials
Revenue
$5.1B
↑ 21.2%
EPS (Diluted)
$6.41
↑ 4173.3%
Operating Income
$1.5B
↑ 2368.6%
Net Income
$1.3B
↑ 3845.0%
Total Assets
$7.0B
↑ 27.8%
Total Liabilities
$1.8B
↓ 10.3%
Cash & Equivalents
$3.1B
↑ 83.5%
Shareholders' Equity
$5.2B
↑ 49.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INCY |
| Company Name | INCYTE CORP |
| CIK | 879169 |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 3024986700 |